Dansk Biogødning A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.2% 1.5% 6.0% 4.5% 2.8%  
Credit score (0-100)  84 75 38 46 58  
Credit rating  A A BBB BBB BBB  
Credit limit (kDKK)  182.3 16.1 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  6,063 4,301 3,390 3,704 5,039  
EBITDA  1,821 1,066 -487 190 847  
EBIT  1,821 1,066 -487 190 847  
Pre-tax profit (PTP)  1,896.9 1,302.3 -363.2 276.6 914.4  
Net earnings  1,479.0 1,008.6 -286.1 210.0 703.4  
Pre-tax profit without non-rec. items  1,897 1,302 -363 277 914  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  3,763 3,071 1,785 1,995 2,698  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9,964 9,172 7,603 7,506 9,802  

Net Debt  -2,181 -2,766 -1,945 -1,967 -1,780  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,063 4,301 3,390 3,704 5,039  
Gross profit growth  9.6% -29.1% -21.2% 9.2% 36.1%  
Employees  0 0 0 0 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9,964 9,172 7,603 7,506 9,802  
Balance sheet change%  7.7% -8.0% -17.1% -1.3% 30.6%  
Added value  1,821.2 1,066.3 -486.9 189.9 847.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  -1.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 -1.0 1.0 2.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  30.0% 24.8% -14.4% 5.1% 16.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  20.6% 14.3% -3.4% 4.5% 11.6%  
ROI %  65.5% 40.1% -11.7% 18.2% 42.9%  
ROE %  48.9% 29.5% -11.8% 11.1% 30.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  37.8% 33.5% 23.5% 26.6% 27.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -119.8% -259.4% 399.5% -1,036.0% -210.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.6 1.5 1.3 1.3 1.4  
Current Ratio  1.6 1.5 1.3 1.3 1.4  
Cash and cash equivalent  2,181.0 2,765.9 1,945.3 1,967.4 1,780.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  3,612.2 2,918.0 1,628.9 1,737.3 2,436.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 212  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 212  
EBIT / employee  0 0 0 0 212  
Net earnings / employee  0 0 0 0 176